Projects

This section presents pharmaceutical projects that are announced from time-to-time around the world.

Bristol Myers Squibb Invests US$400 million to Expand Sterile Drug Product Facility in Dublin, Ireland

Bristol Myers Squibb invests US$400 million to expand its campus in Dublin, Ireland, by incorporating a new sterile drug product facility

SCHOTT Pharma Plans to Open New Production Facility in Jagodina, Serbia

SCHOTT Pharma is investing a multimillioneuro investment to open a stateoftheart production facility for pharmaceutical drug containment solutions and delivery systems in Jagodina, Serbia

AstraZeneca Invests US$300 million to Open New Manufacturing Facility in Maryland, USA

AstraZeneca invests US$300 million to open a stateoftheart manufcaturing facility in Maryland, USA The Rockville facility aims to enhance its manufacturing

AbbVie Invests US$223 million to Expand Biologics Manufacturing Site in Singapore

AbbVie invests US$223 million to expand biologics manufacturing capacity in Singapore

Sai Life Sciences Expands its Laboratory Capabilities in India

Sai Life Sciences expands its DMPK capabilities The expansion of DMPK capabilities augments integrated drug discovery offerings in India

APC and VLE Therapeutics Invests US$108 million (€100 million) to Open Medicine Campus in Dublin, Ireland

APC and VLE Therapeutics are investing US$108 million 100 million for the groundbreaking expansion of medicine accelerator campus in Dublin, Ireland

Genevoyager Plans for the Construction of New Gene Therapy CDMO Facility in USA

Genevoyager unveils stateoftheart gene therapy contract development and manufacturing organisation CDMO facility in USA The newly inaugurated cGMP facility boasts stateoftheart infrastructure

Boehringer Ingelheim Invests US$130 million (€120 million) to Expand its Production Site in Greece

Boehringer Ingelheim invests US$130 mn 120 mn to expand its production site in Greece The expansion project will result in a boosted manufacturing capacity

Upperton Pharma Solutions Invests US$6.3 million (£5million) to Expand Sterile Manufacturing Facility in UK

Upperton Pharma Solutions invests US$63 million 5million to expand its sterile drug manufacturing capacity The newly designed sterile facility will incorporate advanced VHP

Leanbio Pro Opens New Manufacturing Facility to Expand its Production Capacity in Barcelona, Spain

Leanbio opens new GMP facilities to expand its production capacities in Barcelona, Spain The site is planned with an area of 4,000 square metres